The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preselection of lung cancer cases using FGFR1 mRNA and gene copy number for treatment with ponatinib.
 
Terry L. Ng
Honoraria - ARIAD; ARIAD/Takeda
Consulting or Advisory Role - Boehringer Ingelheim
 
Hui Yu
No Relationships to Disclose
 
Derek Smith
No Relationships to Disclose
 
Theresa A. Boyle
Other Relationship - Bristol-Myers Squibb
 
Emily R. York
No Relationships to Disclose
 
Scott Leedy
No Relationships to Disclose
 
Dexiang Gao
No Relationships to Disclose
 
Lynn Heasley
No Relationships to Disclose
 
Fred R. Hirsch
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Genentech; HTG Molecular Diagnostics; Lilly; Merck; Pfizer; Roche; Ventana Medical Systems
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Lilly/ImClone (Inst)
Patents, Royalties, Other Intellectual Property - EGFR FISH and IHC for prediction of outcome in patients treated with EGFR inhibitors (Inst)
 
D. Ross Camidge
Honoraria - AstraZeneca; bio-thera; Daiichi Sankyo; G1 therapeutics; Genoptix; Hansoh; Ignyta; Lycera; Mersana; Revolution Medicines; Roche; takeda
Research Funding - Takeda